Clinical trial · Observational
Promoting Earlier Detection of Breast Cancer in Rwanda: Scaleup in the National Health Care System
NCT04258085CI-TRIAL-00057628completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This observational study evaluates scale-up of a breast cancer early detection program in Rwanda that was initially piloted in a single district. Specifically investigators will examine patient volume, service delivery, loss-to-follow-up rates, and cancer detection rates noted following implementation of scale-up to 3 additional districts. For scaleup, breast cancer screening with CBE was added to a cervical cancer screening initiative, in a combined Women's Cancer Early Detection Program (WCEDP).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Breast Disease | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Early diagnosis program combined with electronic medical record | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Screening plus EMR
- description
- Individuals in this group are those residing in districts where health facilities have implemented a breast cancer screening program integrated with cervical cancer screening, the Women's Cancer Early Detection Program (WCEDP).
- interventionNames
- Other: Early diagnosis program combined with electronic medical record
Primary outcomes (3)
- measure
- Cancer detection rate
- timeFrame
- 2 years
- description
- Proportion of patients presenting to health centers who are ultimately diagnosed with cancer; proportion of patients who receive biopsy who are ultimately diagnosed with cancer; proportion of individuals diagnosed with cancer who initially presented with versus without breast symptoms
- measure
- Loss to follow-up
- timeFrame
- one year
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All women and men who are evaluated for a breast concern or receive breast cancer screening through implementation of the nationally-led early detection programs Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.